Micronutrient deficiencies in inflammatory bowel disease

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 18, Issue 6, 2015, Pages 576-581

  Weisshof, Roni ^a   Chermesh, Irit ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Inflammatory Bowel Disease; Malnutrition; Micronutrients

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; IRON; PYRIDOXINE; RETINOL; SELENIUM; THIAMINE; TRACE ELEMENT; VITAMIN D; VITAMIN K GROUP; ZINC; VITAMIN;

CLINICAL FEATURE; CROHN DISEASE; CYANOCOBALAMIN DEFICIENCY; DISEASE ASSOCIATION; EVIDENCE BASED PRACTICE; FOLIC ACID DEFICIENCY; HUMAN; INFLAMMATORY BOWEL DISEASE; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; MICRONUTRIENT DEFICIENCY; NONHUMAN; NUTRITIONAL DEFICIENCY; PATHOGENESIS; PRACTICE GUIDELINE; RETINOL DEFICIENCY; REVIEW; SELENIUM DEFICIENCY; ULCERATIVE COLITIS; VITAMIN D DEFICIENCY; VITAMIN K DEFICIENCY; ZINC DEFICIENCY; AVITAMINOSIS; BLOOD; COMPLICATION; DEFICIENCY; DEFICIENCY DISEASES; NUTRITIONAL STATUS;

AVITAMINOSIS; COLITIS, ULCERATIVE; CROHN DISEASE; DEFICIENCY DISEASES; HUMANS; MICRONUTRIENTS; NUTRITIONAL STATUS; TRACE ELEMENTS; VITAMINS;

EID: 84944052636     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000226     Document Type: Review

References (51)

1. Kalantari H, Barekat SM, Maracy MR, et al. Nutritional status in patients with ulcerative colitis in Isfahan. Iran Adv Biomed Res 2014; 3:58.
2. OSullivan M. Symposium on The challenge of translating nutrition research into public health nutrition. Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on Nutrition and autoimmune disease Nutrition in Crohns disease. Proc Nutr Soc 2009; 68:127-134.
3. Nguyen GC, Munsell M, Harris ML. Nationwide prevalence and prognostic significance of clinically diagnosable protein-calorie malnutrition in hospitalized inflammatory bowel disease patients. Inflamm Bowel Dis 2008; 14:1105-1111.
4. Van Gossum A, Cabre E, Hebuterne X, et al. ESPEN guidelines on parenteral nutrition: gastroenterology. Clin Nutr 2009; 28:415-427.
5. Massironi S, Rossi RE, Cavalcoli FA, et al. Nutritional deficiencies in inflammatory bowel disease: Therapeutic approaches. Clin Nutr 2013; 32:904-910.
6. Gasche C, Lomer MC, Cavill I, et al. Iron, anaemia, and inflammatory bowel diseases. Gut 2004; 53:1190-1197.
7. Bergamaschi G, Di Sabatino A, Albertini R, et al. Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of antitumor necrosis factor-Alpha treatment. Haematologica 2010; 95:199-205.
8. Lupu A, Diculescu M, Diaconescu R, et al. Prevalence of anemia and iron deficiency in Romanian patients with inflammatory bowel disease: A prospective multicenter study. J Gastrointestin Liver Dis 2015; 24:15-20.
9. Antunes CV, Hallack Neto AE, Nascimento CR, et al. Anemia in inflammatory bowel disease outpatients: prevalence, risk factors, and etiology. Biomed Res Int 2015; 2015:728925.
10. Alves RA, Miszputen SJ, Figueiredo MS. Anemia in inflammatory bowel disease: prevalence, differential diagnosis and association with clinical and laboratory variables. Sao Paulo Med J 2014; 132:140-146.
11. Dignass AU, Gasche C, Bettenworth D, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis 2015; 9:211-222.
12. Rogler G, Vavricka S. Anemia in inflammatory bowel disease: An underestimated problem? Front Med (Lausanne) 2014; 1:58.
13. Stein J, Hartmann F, Dignass AU. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol 2010; 7:599-610.
14. Goldenberg BA, Graff LA, Clara I, et al. Is iron deficiency in the absence of anemia associated with fatigue in inflammatory bowel disease? Am J Gastroenterol 2013; 108:1392-1397.
15. Cortes X, Borras-Blasco J, Moles JR, et al. Safety of ferric carboxymaltose immediately after infliximab administration, in a single session, in inflammatory bowel disease patients with iron deficiency: A pilot study. PLoS One 2015; 10:e0128156.
16. Gasche C, Ahmad T, Tulassay Z, et al. Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program. Inflamm Bowel Dis 2015; 21:579-588.
17. Lindgren S, Wikman O, Befrits R, et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol 2009; 44:838-845.
18. Reinisch W, Staun M, Tandon RK, et al. A randomized, open-label, noninferiority study of intravenous iron isomaltoside 1, 000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED). Am J Gastroenterol 2013; 108:1877-1888.
19. Iqbal T, Stein J, Sharma N, et al. Clinical significance of C-reactive protein levels in predicting responsiveness to iron therapy in patients with inflammatory bowel disease and iron deficiency anemia. Dig Dis Sci 2015; 60:1375-1381.
20. Blumenstein I, Dignass A, Vollmer S, et al. Current practice in the diagnosis and management of IBD-Associated anaemia and iron deficiency in Germany: The German AnaemIBD Study. J Crohns Colitis 2014; 8:1308-1314.
21. Roni Weisshof TM, Irit Chermesh. Iron, B12, and folic acid have we forgotten the ABC? United Eur Gastroenterol J; 2014: 2 (Suppl 1).
22. Battat R, Kopylov U, Szilagyi A, et al. Vitamin B12 deficiency in inflammatory bowel disease: prevalence, risk factors, evaluation, and management. Inflamm Bowel Dis 2014; 20:1120-1128.
23. Yakut M, Ustun Y, Kabacam G, et al. Serum vitamin B12 and folate status in patients with inflammatory bowel diseases. Eur J Intern Med 2010; 21:320-323.
24. Bermejo F, Algaba A, Guerra I, et al. Should we monitor vitamin B12 and folate levels in Crohns disease patients? Scand J Gastroenterol 2013; 48:1272-1277.
25. Bermejo F, Algaba A, Guerra I, et al. Response to letter: folate deficiency in Crohns disease. Scand J Gastroenterol 2014; 49:255-256.
26. Gilfix BM. Utility of measuring serum or red blood cell folate in the era of folate fortification of flour. Clin Biochem 2014; 47 (7-8):533-538.
27. Hashemi J, Asadi J, Amiriani T, et al. Serum vitamins A and E deficiencies in patients with inflammatory bowel disease. Saudi Med J 2013; 34:432-434.
28. Alkhouri RH, Hashmi H, Baker RD, et al. Vitamin and mineral status in patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2013; 56:89-92.
29. da Rocha Lima B, Pichi F, Lowder CY. Night blindness and Crohns disease. Int Ophthalmol 2014; 34:1141-1144.
30. Soares-Mota M, Silva TA, Gomes LM, et al. High prevalence of vitamin A deficiency in Crohns disease patients according to serum retinol levels and the relative dose-response test. World J Gastroenterol 2015; 21:1614-1620.
31. Mouli VP, Ananthakrishnan AN. Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther 2014; 39:125-136.
32. Tan B, Li P, Lv H, et al. Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease. J Dig Dis 2014; 15:116-123.
33. Li YC, Chen Y, Du J. Critical roles of intestinal epithelial vitamin D receptor signaling in controlling gut mucosal inflammation. J Steroid Biochem Mol Biol 2015; 148:179-183.
34. Ooi JH, Li Y, Rogers CJ, et al. Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis. J Nutr 2013; 143:1679-1686.
35. Torki M, Gholamrezaei A, Mirbagher L, et al. Vitamin D deficiency associated with disease activity in patients with inflammatory bowel diseases. Dig Dis Sci 2015. [Epub ahead of print]
36. Bartels LE, Bendix M, Hvas CL, et al. Oral vitamin D3 supplementation reduces monocyte-derived dendritic cell maturation and cytokine production in Crohns disease patients. Inflammopharmacology 2014; 22:95-103.
37. Dadaei T, Safapoor MH, Asadzadeh Aghdaei H, et al. Effect of vitamin D3 supplementation on TNF-Alpha serum level and disease activity index in Iranian IBD patients. Gastroenterol Hepatol Bed Bench 2015; 8:49-55.
38. Yang L, Weaver V, Smith JP, et al. Therapeutic effect of vitamin D supplementation in a pilot study of Crohns patients. Clin TranslGastroenterol 2013; 4:e33.
39. Zator ZA, Cantu SM, Konijeti GG, et al. Pretreatment 25-hydroxyvitamin D levels and durability of antitumor necrosis factor-Alpha therapy in inflammatory bowel diseases. JPEN J Parenter Enteral Nutr 2014; 38:385-391.
40. Nowak JK, Grzybowska-Chlebowczyk U, Landowski P, et al. Prevalence and correlates of vitamin K deficiency in children with inflammatory bowel disease. Sci Rep 2014; 4:4768.
41. Schoon EJ, Muller MC, Vermeer C, et al. Low serum and bone vitamin K status in patients with longstanding Crohns disease: Another pathogenetic factor of osteoporosis in Crohns disease? Gut 2001; 48:473-477.
42. Geerling BJ, Badart-Smook A, Stockbrugger RW, et al. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur J Clin Nutr 2000; 54:514-521.
43. Barrett CW, Singh K, Motley AK, et al. Dietary selenium deficiency exacerbates DSS-induced epithelial injury and AOM/DSS-induced tumorigenesis. PLoS One 2013; 8:e67845.
44. Krehl S, Loewinger M, Florian S, et al. Glutathione peroxidase-2 and selenium decreased inflammation and tumors in a mouse model of inflammationassociated carcinogenesis whereas sulforaphane effects differed with selenium supply. Carcinogenesis 2012; 33:620-628.
45. Hiller F, Oldorff L, Besselt K, et al. Differential acute effects of selenomethionine and sodium selenite on the severity of colitis. Nutrients 2015; 7:2687-2706.
46. Vagianos K, Bector S, McConnell J, et al. Nutrition assessment of patients with inflammatory bowel disease. JPEN J Parenter Enteral Nutr 2007; 31:311-319.
47. Santucci NR, Alkhouri RH, Baker RD, et al. Vitamin and zinc status pretreatment and posttreatment in patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2014; 59:455-457.
48. Wong CP, Rinaldi NA, Ho E. Zinc deficiency enhanced inflammatory response by increasing immune cell activation and inducing IL6 promoter demethylation. Mol Nutr Food Res 2015; 59:991-999.
49. Larnaout A, El-Euch G, Kchir N, et al. Wernickes encephalopathy in a patient with Crohns disease: A pathological study. J Neurol 2001; 248: 57-60.
50. Cho DD, Austin PC, Atzema CL. Management of Discharged Emergency Department Patients with a primary diagnosis of hypertension: A multicentre study. CJEM 2015; 17:523-531.
51. Costantini A, Pala MI. Thiamine and fatigue in inflammatory bowel diseases: An open-label pilot study. J Altern Complement Med 2013; 19:704-708.